Expression of cell cycle-regulated proteins in prostate cancer

Robert D. Mashal, Susan Lester, Christopher Corless, Jerome P. Richie, Reena Chandra, Kathleen J. Propert, Anindya Dutta

Research output: Contribution to journalArticle

116 Citations (Scopus)

Abstract

Markers of cellular proliferation have proven to be useful prognostic markers in several tumor types. Recently, immunoreactivity for cyclins was found to provide an independent marker of tumor proliferation in breast cancer. In this study, we sought to determine the pattern of immunoreactivity for cyclins A, B, E, and Ki-67 in surgically resected prostate cancer and to determine their possible prognostic significance. Twenty-eight tumors of American Urological Association stages B and C were selected for study. Immunoreactivity for cyclins A and B was detected in most tumors and was present at significantly reduced levels as compared with breast cancer. Staining for cyclin E was present in four tumors and was present only in focal areas in two of the four. Such focal variation in expression of cell cycle regulators may reflect genetic instability in a tumor. Immunoreactivity for cyclins A and B was correlated with both Ki-67 index (the percentage of cells with Ki-67 immunoreactivity) and with each other. A Ki-67 index greater than 4.0 was associated with shorter time to prostate-specific antigen- detected relapse (P = 0.026). The fraction of cells staining for cyclins A and B divided by the fraction of cells staining for Ki-67 [(A + B)/K] was highly predictive of relapse, with values less than 0.50 associated with more rapid progression (P <0.001). This latter result remained statistically significant after controlling for Gleason score by stratification. Our results suggest that immunoreactivity for markers of cellular proliferation may provide useful prognostic information in localized prostate cancer, and they need to be validated in a larger numbers of patients.

Original languageEnglish (US)
Pages (from-to)4159-4163
Number of pages5
JournalCancer Research
Volume56
Issue number18
StatePublished - Sep 15 1996
Externally publishedYes

Fingerprint

Cell Cycle Proteins
Cyclin B
Cyclin A
Prostatic Neoplasms
Neoplasms
Staining and Labeling
Cell Proliferation
Breast Neoplasms
Recurrence
Cyclin E
Cyclins
Neoplasm Grading
Prostate-Specific Antigen
Tumor Biomarkers
Cell Cycle

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mashal, R. D., Lester, S., Corless, C., Richie, J. P., Chandra, R., Propert, K. J., & Dutta, A. (1996). Expression of cell cycle-regulated proteins in prostate cancer. Cancer Research, 56(18), 4159-4163.

Expression of cell cycle-regulated proteins in prostate cancer. / Mashal, Robert D.; Lester, Susan; Corless, Christopher; Richie, Jerome P.; Chandra, Reena; Propert, Kathleen J.; Dutta, Anindya.

In: Cancer Research, Vol. 56, No. 18, 15.09.1996, p. 4159-4163.

Research output: Contribution to journalArticle

Mashal, RD, Lester, S, Corless, C, Richie, JP, Chandra, R, Propert, KJ & Dutta, A 1996, 'Expression of cell cycle-regulated proteins in prostate cancer', Cancer Research, vol. 56, no. 18, pp. 4159-4163.
Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ et al. Expression of cell cycle-regulated proteins in prostate cancer. Cancer Research. 1996 Sep 15;56(18):4159-4163.
Mashal, Robert D. ; Lester, Susan ; Corless, Christopher ; Richie, Jerome P. ; Chandra, Reena ; Propert, Kathleen J. ; Dutta, Anindya. / Expression of cell cycle-regulated proteins in prostate cancer. In: Cancer Research. 1996 ; Vol. 56, No. 18. pp. 4159-4163.
@article{9c8bd04f13944eff8a6a9cefa7c33d0f,
title = "Expression of cell cycle-regulated proteins in prostate cancer",
abstract = "Markers of cellular proliferation have proven to be useful prognostic markers in several tumor types. Recently, immunoreactivity for cyclins was found to provide an independent marker of tumor proliferation in breast cancer. In this study, we sought to determine the pattern of immunoreactivity for cyclins A, B, E, and Ki-67 in surgically resected prostate cancer and to determine their possible prognostic significance. Twenty-eight tumors of American Urological Association stages B and C were selected for study. Immunoreactivity for cyclins A and B was detected in most tumors and was present at significantly reduced levels as compared with breast cancer. Staining for cyclin E was present in four tumors and was present only in focal areas in two of the four. Such focal variation in expression of cell cycle regulators may reflect genetic instability in a tumor. Immunoreactivity for cyclins A and B was correlated with both Ki-67 index (the percentage of cells with Ki-67 immunoreactivity) and with each other. A Ki-67 index greater than 4.0 was associated with shorter time to prostate-specific antigen- detected relapse (P = 0.026). The fraction of cells staining for cyclins A and B divided by the fraction of cells staining for Ki-67 [(A + B)/K] was highly predictive of relapse, with values less than 0.50 associated with more rapid progression (P <0.001). This latter result remained statistically significant after controlling for Gleason score by stratification. Our results suggest that immunoreactivity for markers of cellular proliferation may provide useful prognostic information in localized prostate cancer, and they need to be validated in a larger numbers of patients.",
author = "Mashal, {Robert D.} and Susan Lester and Christopher Corless and Richie, {Jerome P.} and Reena Chandra and Propert, {Kathleen J.} and Anindya Dutta",
year = "1996",
month = "9",
day = "15",
language = "English (US)",
volume = "56",
pages = "4159--4163",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "18",

}

TY - JOUR

T1 - Expression of cell cycle-regulated proteins in prostate cancer

AU - Mashal, Robert D.

AU - Lester, Susan

AU - Corless, Christopher

AU - Richie, Jerome P.

AU - Chandra, Reena

AU - Propert, Kathleen J.

AU - Dutta, Anindya

PY - 1996/9/15

Y1 - 1996/9/15

N2 - Markers of cellular proliferation have proven to be useful prognostic markers in several tumor types. Recently, immunoreactivity for cyclins was found to provide an independent marker of tumor proliferation in breast cancer. In this study, we sought to determine the pattern of immunoreactivity for cyclins A, B, E, and Ki-67 in surgically resected prostate cancer and to determine their possible prognostic significance. Twenty-eight tumors of American Urological Association stages B and C were selected for study. Immunoreactivity for cyclins A and B was detected in most tumors and was present at significantly reduced levels as compared with breast cancer. Staining for cyclin E was present in four tumors and was present only in focal areas in two of the four. Such focal variation in expression of cell cycle regulators may reflect genetic instability in a tumor. Immunoreactivity for cyclins A and B was correlated with both Ki-67 index (the percentage of cells with Ki-67 immunoreactivity) and with each other. A Ki-67 index greater than 4.0 was associated with shorter time to prostate-specific antigen- detected relapse (P = 0.026). The fraction of cells staining for cyclins A and B divided by the fraction of cells staining for Ki-67 [(A + B)/K] was highly predictive of relapse, with values less than 0.50 associated with more rapid progression (P <0.001). This latter result remained statistically significant after controlling for Gleason score by stratification. Our results suggest that immunoreactivity for markers of cellular proliferation may provide useful prognostic information in localized prostate cancer, and they need to be validated in a larger numbers of patients.

AB - Markers of cellular proliferation have proven to be useful prognostic markers in several tumor types. Recently, immunoreactivity for cyclins was found to provide an independent marker of tumor proliferation in breast cancer. In this study, we sought to determine the pattern of immunoreactivity for cyclins A, B, E, and Ki-67 in surgically resected prostate cancer and to determine their possible prognostic significance. Twenty-eight tumors of American Urological Association stages B and C were selected for study. Immunoreactivity for cyclins A and B was detected in most tumors and was present at significantly reduced levels as compared with breast cancer. Staining for cyclin E was present in four tumors and was present only in focal areas in two of the four. Such focal variation in expression of cell cycle regulators may reflect genetic instability in a tumor. Immunoreactivity for cyclins A and B was correlated with both Ki-67 index (the percentage of cells with Ki-67 immunoreactivity) and with each other. A Ki-67 index greater than 4.0 was associated with shorter time to prostate-specific antigen- detected relapse (P = 0.026). The fraction of cells staining for cyclins A and B divided by the fraction of cells staining for Ki-67 [(A + B)/K] was highly predictive of relapse, with values less than 0.50 associated with more rapid progression (P <0.001). This latter result remained statistically significant after controlling for Gleason score by stratification. Our results suggest that immunoreactivity for markers of cellular proliferation may provide useful prognostic information in localized prostate cancer, and they need to be validated in a larger numbers of patients.

UR - http://www.scopus.com/inward/record.url?scp=0029832293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029832293&partnerID=8YFLogxK

M3 - Article

C2 - 8797586

AN - SCOPUS:0029832293

VL - 56

SP - 4159

EP - 4163

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 18

ER -